- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Non-alcoholic Steatohepatitis
Total 1402 results
-
NGM Biopharmaceuticals, IncCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Australia, Belgium, France, Germany, Hong Kong, Poland, Puerto Rico, United Kingdom
-
CelgeneTerminatedLiver Cirrhosis | Non-alcoholic Fatty Liver DiseaseUnited States, Spain, Australia, Korea, Republic of, Canada, Germany, France, Japan, United Kingdom, Poland
-
Naga P. ChalasaniDSM Nutritional Products, Inc.CompletedNon-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Non-Alcoholic Fatty LiverUnited States
-
Enanta Pharmaceuticals, IncTerminatedNon-Alcoholic SteatohepatitisUnited States, Canada, Puerto Rico, United Kingdom, Argentina, Germany
-
Enyo PharmaCompletedNon-alcoholic SteatohepatitisUnited States, Belgium, France, Puerto Rico, United Kingdom
-
Sidekick HealthHjartamiðstöðin, Iceland; Hjartavernd, IcelandCompletedNon Alcoholic Fatty Liver DiseaseIceland
-
Akero Therapeutics, IncActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Mexico, Puerto Rico
-
ChemomAb Ltd.Completed
-
Akero Therapeutics, IncActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
AstraZenecaCompleted
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Canada
-
AstraZenecaTerminatedNon-alcoholic SteatohepatitisGermany
-
Fondazione Policlinico Universitario Agostino Gemelli...Active, not recruitingWeight Loss | Bariatric Surgery Candidate | NASH With FibrosisItaly
-
Zhejiang Medicine Co., Ltd.The Affiliated Hospital of Hangzhou Normal University; R&G Pharma Studies Co...CompletedNASH (Non-Alcoholic Steatohepatitis)China
-
Corcept TherapeuticsCompletedNon-alcoholic Steatohepatitis (NASH) | Antipsychotic Induced Weight GainUnited States
-
Regeneron PharmaceuticalsTerminatedNon-alcoholic Steatohepatitis (NASH)Brazil, United States, Puerto Rico, Korea, Republic of, Mexico
-
MediciNovaCompletedNon-alcoholic Fatty Liver Disease | Hypercholesterolemia | Hypertriglyceridemia | Non-alcoholic SteatohepatitisUnited States
-
Cairo UniversityCompleted
-
Gannex Pharma Co., Ltd.WithdrawnNonalcoholic Steatohepatitis (NASH)
-
CytoDyn, Inc.Amarex Clinical ResearchCompletedNonalcoholic Steatohepatitis (NASH)United States
-
The Geneva FoundationTerminatedNon-Alcoholic Fatty Liver Disease | Non Alcoholic SteatohepatitisUnited States
-
The Geneva FoundationTerminatedObesity, Childhood | Hemosiderosis | Liver Steatosis | Steatohepatitis, Nonalcoholic | Overweight AdolescentsUnited States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Yale UniversityWithdrawn
-
Catholic University of the Sacred HeartUniversity of Roma La SapienzaCompletedNon Alcoholic SteatohepatitisItaly
-
Dongguan HEC Biopharmaceutical R&D Co., Ltd.CompletedThe Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy SubjectsNon-alcoholic SteatohepatitisAustralia
-
Philips Clinical & Medical Affairs GlobalCompletedNon-Alcoholic Fatty Liver Disease | Non-Alcoholic SteatohepatitisUnited States
-
MedImmune LLCCompletedNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)United States, Puerto Rico
-
Sinew Pharma Inc.TerminatedNASH - Nonalcoholic SteatohepatitisTaiwan
-
Meridian Bioscience, Inc.CompletedNon-Alcoholic SteatohepatitisUnited States, France, Belgium, United Kingdom
-
Meridian Bioscience, Inc.Bristol-Myers SquibbCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Meridian Bioscience, Inc.Conatus PharmaceuticalsCompletedCirrhosis | Portal Hypertension | NASH - Nonalcoholic SteatohepatitisFrance
-
Better TherapeuticsArizona Liver HealthCompletedNon-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Non-alcoholic Fatty LiverUnited States
-
Sonic IncytesActive, not recruitingLiver Fibroses | Non-Alcoholic Fatty Liver Disease (NAFLD) | Non-Alcoholic Steatohepatitis (NASH) | Liver SteatosesUnited States
-
Altimmune, Inc.Completed
-
University Health Network, TorontoNovo Nordisk A/SEnrolling by invitationDiabetes Mellitus | NAFLD | NASH - Nonalcoholic Steatohepatitis | Liver Transplant; ComplicationsCanada
-
University of AarhusDanish Council for Independent ResearchCompletedGlucose Metabolism Disorders | Non-Alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisDenmark
-
GenfitPremier Research Group plc; NaturalphaCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Belgium, France, Germany, Italy, Netherlands, Romania, Spain, United Kingdom
-
Johane AllardCanadian Institutes of Health Research (CIHR)Active, not recruitingNon-alcoholic Fatty Liver Disease | Morbid ObesityCanada
-
JD Bioscience Inc.Novotech (Australia) Pty LimitedEnrolling by invitation
-
Bristol-Myers SquibbCompletedNonalcoholic Steatohepatitis | Liver Fibrosis | Nonalcoholic Fatty Liver Disease (NAFLD) | Hepatic CirrhosisUnited States, Japan
-
Georgetown UniversityCompletedNonalcoholic SteatohepatitisUnited States
-
AstraZenecaQuotient SciencesCompletedChronic Kidney Disease | Type 2 Diabetes Mellitus (T2DM) | Non-alcoholic SteatohepatitisUnited Kingdom
-
William Beaumont HospitalsTerminatedFibrosis, Liver | Cirrhosis, Liver | Steatohepatitis, Nonalcoholic | Fatty Liver DiseaseUnited States
-
Yokohama City UniversityActive, not recruitingNonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverJapan
-
Hepagene (Shanghai) Co., Ltd.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
CymaBay Therapeutics, Inc.TerminatedNASH - Nonalcoholic SteatohepatitisUnited States
-
Oramed, Ltd.IntegriumCompletedDiabetes Mellitus, Type 2 | NASH - Nonalcoholic SteatohepatitisUnited States, Israel
-
Bristol-Myers SquibbCompletedNonalcoholic Steatohepatitis | Liver Fibrosis | Nonalcoholic Fatty Liver Disease (NAFLD)United States, Japan
-
LISCure BiosciencesCompletedRheumatoid Arthritis | Non-Alcoholic SteatohepatitisAustralia
-
Corcept TherapeuticsTerminatedNonalcoholic Steatohepatitis (NASH)United States